[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338318-105":59,"doc-detail-338318-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","massively-parallel-reporter-assays-identify-enhancer-elements-in-oesophageal-adenocarcinoma","Massively parallel reporter assays identify enhancer elements in oesophageal Adenocarcinoma","","Cancer is a disease driven by aberrant gene expression, and enhancers are key regulatory elements shaping transcription. Using STARR-seq, the study profiles the genome-wide enhancer landscape in oesophageal adenocarcinoma (OAC) to pinpoint hundreds of high-confidence enhancer elements. These enhancers show enhancer-associated chromatin signatures, active transcription, and strong gene-activity readouts in OAC cells, preserved in human patient samples. Disease relevance is supported by responsiveness to ERBB2 inhibition and increased activity versus Barrett’s pre-cancerous state. Mechanistic links connect enhancers to the OAC transcriptional network, with KLF5 binding correlating with high activity, supporting KLF5 involvement in the OAC transcriptome. The results highlight enhancer elements with physiological significance and suggest mechanisms underlying targeted-therapy response.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/massively-parallel-reporter-assays-identify-enhancer-elements-in-oesophageal-adenocarcinoma/338318/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/massively-parallel-reporter-assays-identify-enhancer-elements-in-oesophageal-adenocarcinoma/338318.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What technique is used to map enhancer elements in oesophageal adenocarcinoma?","Question",{"text":112,"@type":113},"The study uses STARR-seq, a massively parallel reporter assay, to profile the genome-wide enhancer landscape in OAC cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What evidence supports that identified enhancers are disease-relevant in patients?",{"text":117,"@type":113},"The enhancer characteristics observed in OAC cells are maintained in human patient samples, and their activity responds to oncogenic ERBB2 inhibition and is increased compared with the pre-cancerous Barrett’s state.",{"name":119,"@type":110,"acceptedAnswer":120},"Which transcription factor is linked to high enhancer activity in OAC?",{"text":121,"@type":113},"KLF5 binding is associated with high levels of enhancer activity, supporting a role for KLF5 in defining the OAC transcriptome.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338318,1790457296,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","NAR Cancer, 2024, 6, zcae041  \n[https://doi.org/10.1093/narcan/zcae041](https://doi.org/10.1093/narcan/zcae041)  \nAdvance access publication date: 16 October 2024  \nCancer Gene Regulation, Chromatin, and Epigenetics  \nMassively parallel reporter assays identify enhancer elements in oesophageal Adenocarcinoma  \nShen-Hsi Yang†, Ibrahim Ahmed†, Yaoyong Li†, Christopher W. Bleaney and Andrew D. Sharrocks *  \nSchool of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK  \n* To whom correspondence should be addressed. Tel: +44 161 275 5979; Fax: +44 161 275 5082; Email: [andrew.d.sharrocks@manchester.ac.uk](andrew.d.sharrocks@manchester.ac.uk)[ ](andrew.d.sharrocks@manchester.ac.uk)†The first three authors are considered to be Joint First Authors.  \nAbstract  \nCancer is a disease underpinned by aberrant gene expression. Enhancers are regulatory elements that play a major role in transcriptional control and changes in active enhancer function are likely critical in the pathogenesis of oesophageal adenocarcinoma (OAC) . Here, we utilise STARR-seq to profile the genome-wide enhancer landscape in OAC and identify hundreds of high-confidence enhancer elements. These regions are enriched in enhancer-associated chromatin marks, are actively transcribed and exhibit high levels of associated gene activity in OAC cells. These characteristics are maintained in human patient samples, demonstrating their disease relevance. This relevance is further underlined by their responsiveness to oncogenic ERBB2 inhibition and increased activity compared to the pre-cancerous Barrett’s state. Mechanistically, these enhancers are linked to the core OAC transcriptional network and in particular KLF5 binding is associated with high level activity, providing further support for a role of this transcription factor in defining the OAC transcriptome. Our results therefore uncover a set of enhancer elements with physiological significance, that widen our understanding of the molecular alterations in OAC and point to mechanisms through which response to targeted therapy may occur.  \nGraphical abstract  \nIntroduction  \nOesophageal adenocarcinoma (OAC) is a gastrointestinal cancer that is one of the leading global causes of cancer-associated deaths (1) . A number a genome-wide DNA-sequencing studies have identified potential disease driver events, including amplifications of genes encoding receptor tyrosine kinases (RTKs) such as ERBB2 (2–4) . Despite this, there is still a paucity of information regarding the specific mechanisms by which disease occurs. We have previously demonstrated that changes to the accessible chromatin landscape are critical in both the onset of disease, and the response to targeted thera-  \npeutic intervention (5–8) . These chromatin changes often occur in regions of the genome that have the potential to function as regulatory elements, such as enhancers, and may represent an underappreciated mechanism by which disease and therapy-resistance is facilitated. This makes the study of en  \nhancer elements in OAC of potential clinical importance.  \nEnhancers are distal regulatory elements that affect the expression of their target genes through long-range interactions with their promoters (9) . The identification of enhancers has largely focused on the use of correlative approaches, linking the presence of histone marks such as H3K27ac and  \nReceived: June 12, 2024. Revised: August 9, 2024. Editorial Decision: September 24, 2024. Accepted: October 9, 2024  \n© The Author(s) 2024. Published by Oxford University Press on behalf of NAR Cancer.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License  \n([https:](https://creativecommons.org/licenses/by-nc/4.0/)[//](https://creativecommons.org/licenses/by-nc/4.0/)[creativecommons.org](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creati","cbCaidQgbHhRuXEG","https://ap.wps.com/l/cbCaidQgbHhRuXEG","pdf",2971037,14,"English","# Abstract\n## Introduction","[{\"question\":\"What technique is used to map enhancer elements in oesophageal adenocarcinoma?\",\"answer\":\"The study uses STARR-seq, a massively parallel reporter assay, to profile the genome-wide enhancer landscape in OAC cells.\"},{\"question\":\"What evidence supports that identified enhancers are disease-relevant in patients?\",\"answer\":\"The enhancer characteristics observed in OAC cells are maintained in human patient samples, and their activity responds to oncogenic ERBB2 inhibition and is increased compared with the pre-cancerous Barrett’s state.\"},{\"question\":\"Which transcription factor is linked to high enhancer activity in OAC?\",\"answer\":\"KLF5 binding is associated with high levels of enhancer activity, supporting a role for KLF5 in defining the OAC transcriptome.\"}]","Massively parallel reporter assays identify enhancer elements in oesophageal Adenocarcinoma | PDF",1790023042,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5feadbe043c7bc4c79061dc7f48529d3.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78c9470188ce50313f74bcc6db68b87a.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/673856c7b81acf76dec0db187ddebf60.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32fb8726ce5812351b566aef938396bd.webp",980,1268]